NASDAQ:ITOS
Delisted

Iteos Therapeutics Stock Insider Trading

etoro logo Buy ITOS
*Your capital is at risk
$10.15
+0 (+0%)
At Close: Nov 28, 2025

Iteos Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -91.32. In total, the insiders bought 1.45M and sold 5.06M ITOS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-91.32
Buy 1.45M shares
Sell 5.06M shares
40% Buy Activity
Weak Positive Correlation
Buy Signal Low Confidence
May 15, 2025

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -91.32.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 10, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 94 027
Value: $404.3K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $36.1K
Jun 10, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 883
Value: $188.7K
Jun 10, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 94 027
Value: $404.3K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 883
Value: $188.7K
Jun 10, 2025
Sell
Common Stock
S-Sale
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $84.2K
Jun 10, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $36.1K
Jun 10, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 18 000
Value: $77.4K
Jun 09, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $188.7K
Jun 09, 2025
Sell
Common Stock
S-Sale
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $84.3K
Jun 09, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $188.7K
Jun 09, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $36.1K
Jun 09, 2025
Sell
Common Stock
S-Sale
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $440.1K
Jun 09, 2025
Sell
Common Stock
S-Sale
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $440.1K
Jun 09, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $36.1K
Jun 09, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $188.7K
Jun 09, 2025
Sell
Common Stock
S-Sale
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $84.3K
Jun 09, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $188.7K
Jun 06, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $188.7K
Jun 06, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $36.1K
Jun 06, 2025
Sell
Common Stock
S-Sale
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $85.8K
Jun 06, 2025
Buy
Common Stock
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $188.7K
Jun 06, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Detheux Michel
Chief Executive Officer
CEO / President 8 400
Value: $36.1K
Jun 06, 2025
Sell
Common Stock
S-Sale
Detheux Michel
Chief Executive Officer
CEO / President 43 882
Value: $448.0K
Jun 06, 2025
Buy
Common Stock
M-Exempt
Hallal David
Director
Director 38 228
Value: $164.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ITEOS THERAPEUTICS INC.
Iteos Therapeutics
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used t...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE